About
Who We Are
Leadership Team
Board of Directors
Clinical and Scientific Advisors
Contact
Science
Immune Continuum
Elevated immunoglobulin E (IgE) in Allergic Conditions
CCR4 in Inflammation
CCR4 in Cancer
Publications
Pipeline
Snapshot
RPT904
Tivumecirnon (FLX475)
Discovery Programs
Investors
Corporate Profile
Press Releases
Events and Presentations
Stock Information
Corporate Governance
SEC Filings
Email Alerts
Investor Contact
Investor FAQs
Careers
Culture
Benefits
Open Positions
PRESS RELEASES
Year
2025
2024
2023
2022
2021
Filter
January 09 | 2025
RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 06 | 2025
RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors
You are leaving RAPT.com to go to the eczema clinical trial study site.
